Image-derived Prediction of Response to Chemo-radiation in Patients With Glioblastoma

Trial Profile

Image-derived Prediction of Response to Chemo-radiation in Patients With Glioblastoma

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Acronyms IDEPREG
  • Most Recent Events

    • 23 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 May 2017.
    • 23 Apr 2017 Status changed from recruiting to discontinued.
    • 14 Oct 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top